TSPAN1 and pharynx neoplasm: Thus, TSPAN1 expression was detected in ~45% (IHC) of laryngeal and pharyngeal tumors, a similar percentage to the upregulation of TSPAN1 detected at mRNA level (8 out of 16 patients) and also by Western blot (eight out of 12 patients).